Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD

NCT01256580 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Lack of eligible subjects.

Conditions

Choroidal Neovascularization
Myopia
Punctate Inner Choroidopathy (PIC)
Multifocal Choroiditis
Ocular Histoplasmosis Syndrome
Central Serous Chorioretinopathy (CSC)
Angioid Streaks
Trauma, or Hereditary Eye Diseases

Interventions

DRUG: Bevacizumab (Avastin; Genentech, Inc.)
DRUG: Bevacizumab, Dexamethasone, Verteporfin Photodynamic Therapy

Sponsor

Massachusetts Eye and Ear Infirmary